Cargando…
Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients
SIMPLE SUMMARY: Gastroesophageal adenocarcinoma (GEA) has a poor prognosis. However, since the HER2 positive subgroup could benefit from trastuzumab targeted therapy, considerable effort has been spent in determining the HER2 status in these patients. To date, immunohistochemistry and in situ hybrid...
Autores principales: | Boldrin, Elisa, Mazza, Marcodomenico, Piano, Maria Assunta, Alfieri, Rita, Montagner, Isabella Monia, Magni, Giovanna, Scaini, Maria Chiara, Vassallo, Loretta, Rosato, Antonio, Pilati, Pierluigi, Scapinello, Antonio, Curtarello, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102116/ https://www.ncbi.nlm.nih.gov/pubmed/35565309 http://dx.doi.org/10.3390/cancers14092180 |
Ejemplares similares
-
MSI Analysis in Solid and Liquid Biopsies of Gastroesophageal Adenocarcinoma Patients: A Molecular Approach
por: Boldrin, Elisa, et al.
Publicado: (2021) -
Using ddPCR to assess the DNA yield of FFPE samples
por: Lu, X.J. David, et al.
Publicado: (2018) -
Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients
por: Boldrin, Elisa, et al.
Publicado: (2020) -
Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
por: Guo, Qiao-mei, et al.
Publicado: (2019) -
p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)